Pro: Intraoperative use of nitric oxide for treatment of pulmonary hypertension in patients with congenital heart disease is effective

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 15, Issue 2, 2001, Pages 259-262

  Mossad, Emad B ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Children; Nitric oxide; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ARTICLE; CARDIOPULMONARY BYPASS; CONGENITAL HEART DISEASE; DRUG EFFICACY; EXTRACORPOREAL CIRCULATION; HUMAN; INTRAOPERATIVE PERIOD; LUNG ARTERY PRESSURE; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SURGICAL RISK;

EID: 0035067661     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2001.21993     Document Type: Article

References (28)

1. The molecule of the year
2. The 1998 Nobel prize winners are announced: Three discoverers of nitric oxide activity
3. Pulmonary hypertension after operations for congenital heart disease: Analysis of risk factors and management
4. Inhaled nitric oxide: Clinical applications, indications and toxicity
5. Inhaled nitric oxide to test the vasodilator capacity of the pulmonary vascular bed in children with long-standing pulmonary hypertension and congenital heart disease
6. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease
7. Inhaled nitric oxide in infants and children after open heart surgery
8. Decreased exhaled nitric oxide may be a marker of cardiopulmonary bypass-induced injury
9. Inhaled nitric oxide in patients with critical pulmonary perfusion after Fontan-type procedures and bi-directional Glenn anastomosis
10. The influence of different strategies on clinical outcome in patients undergoing total cavopulmonary connection
11. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension
12. Influence of hydrogen ion concentration versus carbon dioxide tension on pulmonary vascular resistance after cardiac operations
13. Nitric oxide, oxygen and prostacyclin in children with pulmonary hypertension
14. Hemodynamic effects of prostaglandin E1 and isoproterenol early after cardiac operations for mitral stenosis
15. Nitric oxide inhalation therapy for newborn infants
16. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial
17. Prolonged pulmonary vasodilator action of inhaled nitric oxide by Zaprinast in awake lambs
18. Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease
19. Dose-response relationship for inhaled nitric oxide in experimental pulmonary hypertension in sheep
20. Inhaled nitric oxide: Selective pulmonary vasodilatation in cardiac surgical patients
21. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide
22. Acute ventilatory restriction in children after weaning off inhaled nitric oxide: Relation to rebound pulmonary hypertension
23. Repair of truncus arteriosus in the neonate
24. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
25. Right ventricular function in patients treated with inhaled nitric oxide after cardiac surgery for congenital heart disease in newborns and children
26. Inhibition of platelet aggregation by inhaled nitric oxide in patients with acute respiratory distress syndrome
27. Nitric oxide from endothelium and smooth muscle modulates responses to sympathetic nerve stimulation: Implications for endotoxic shock
28. Delivery and monitoring of inhaled nitric oxide in patients with pulmonary hypertension